Steven W. Lefkowitz - 26 Jan 2026 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role: Director
Signature: /s/ Beth Zelnick Kaufman, attorney-in-fact
Issuer symbol: CRMD
Transactions as of: 26 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 27 Jan 2026, 21:30:05 UTC
Previous filing: 14 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Lefkowitz Steven W	Director	C/O CORMEDIX INC., 389 INTERPACE PKWY, SUITE 450, PARSIPPANY	/s/ Beth Zelnick Kaufman, attorney-in-fact	27 Jan 2026	0001313149

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRMD	Common Stock	Award	$0	+30,453	+32%	$0.000000	125,951	26 Jan 2026	Direct	F1
holding	CRMD	Common Stock						30,152	26 Jan 2026	Wade Capital Corporation Money Purchase Plan	F2
holding	CRMD	Common Stock						2,000	26 Jan 2026	Reporting Person's Wife

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date.
F2	The Reporting Person beneficially owns these securities through Wade Capital Corporation Money Purchase Plan (an entity for which the Reporting Person has voting and investment control).